📰 Merck Sharp News
Page 86 - Merck Sharp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Merck Sharp. Real-time updates on events, politics, business and more.
January 13, 2022
Vaccines: Pharmaceutical Technology top tweets on infectious diseases in Q4 2021, based on GlobalData’s Pharmaceuticals Influencer Platform.
January 13, 2022
North America Human Insulin Drugs and Delivery Devices Market analysis report gives a clear idea on various segments that are relied upon to observe the quickest business development amid the estimated forecast frame. This report indicates a professional and all-inclusive study of the market which concentrates on pr...
January 12, 2022
Taipei, Jan. 12 (CNA) The Central Epidemic Command Center (CECC) on Wednesday publicized regulations on the use of the oral antiviral pill molnupiravir, made by drugmaker Merck, which has been granted emergency use authorization (EUA) in Taiwan.
January 11, 2022
Adding tucatinib to trastuzumab and capecitabine provides a lasting survival benefit for patients with HER2+ metastatic breast cancer.
January 11, 2022
Washington, (11-01-2022) – Databridgemarketresearch.com announces the release of the report “Intra-Abdominal Infections Market ” Size, Share & Trends Analysis Report By 2029. This research report includes the profiles of the key companies along with their SWOT analysis and market strategies. In addition, this Intra-...
January 11, 2022
Washington, (10101-2022) – Databridgemarketresearch.com announces the release of the report “Camurati-Engelmann Disease Treatment Market  ” Size, Share & Trends Analysis Report By 2029. This report covers the present scenario and the growth prospects of the global market and includes a discussion of the key vendors...
January 11, 2022
Gene Expression Analysis Market analysis report gives a clear idea on various segments that are relied upon to observe the quickest business development amid the estimated forecast frame. This report indicates a professional and all-inclusive study of the market which concentrates on primary and secondary drivers, m...
January 10, 2022
/PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), today announced it will participate in a study pursuant to a clinical trial...
January 10, 2022
SHANGHAI, Jan. 10, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), today announced it will participate in a study pursuant to a clinical trial collaboration between Gilead and MSD (Merck & Co., Inc., Kenilworth, NJ., USA) to evaluate the combination of the Trop-2 targeting antibody-drug conjugate (ADC) Trodelvy® (sacituzumab govitecan) and MSD's anti-PD-1 therapy KEYTRUDA® (pembrolizumab)...
January 8, 2022
A systematic review and meta-analysis of 44 clinical studies published between January and August 2021, finds an overall reasonable response to COVID-19 vaccinations for patients with underlying hematological malignancies. The authors describe an urgent need for more effective regimens for high-risk patients. The study was made available as a preprint on medRxiv on November 8, 2021, and has not ye